Evidence map›Paper›PMID 29540226›Full record

ArticleJournal of biomedical science2018

Vasoactive intestinal peptide alleviates osteoarthritis effectively via inhibiting NF-κB signaling pathway.

Yaozhong Liang, Shu Chen, Yuhao Yang, Chunhai Lan, Guowei Zhang, Zhisheng Ji, Hongsheng Lin

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yaozhong LiangDepartment of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Shu ChenDepartment of gynaecology and obstetrics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Yuhao YangDepartment of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Chunhai LanDepartment of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Guowei ZhangDepartment of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Zhisheng JiDepartment of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Hongsheng LinDepartment of Orthopedics, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China. linhs2016@sina.com.
First Affiliated Hospital of Jinan University · CN

Funding

the Natural Science Foundation of Guangdong Province NO. 2014A030313357
6 · The paper itself

Abstract

backgroundTo investigate the treatment effect of vasoactive intestinal peptide (VIP) on osteoarthritis (OA) and the relative mechanism.

methodThe OA model on the SD rat knee was established using the modified Hulth method, and the recombinant pcDNA3.1+/VIP plasmid was constructed. One month after the plasmids VIP were injected intra-articularly into the right knee joint of OA and sham-operated rats, the pathological changes of the OA knee joint were observed by Hematoxylin-eosin (HE) and Safranin O/fast green staining. The levels of VIP and serum inflammatory cytokines (TNF-α, IL-2 and IL-4) were measured by ELISA kits. Meanwhile, synoviocytes isolated from OA rat and sham-operated rat were cultured in vitro, and transfected with the VIP plasmid. The proliferation of synoviocytes was determined using BrdU kits. The protein expressions of TNF-α, IL-2, CollagenII, osteoprotegerin (OPG), matrix-degrading enzymes (MMP-13, ADAMTS-5), and the related protein of NF-κB signaling pathway (phosphorylated p65, phosphorylated IκBα) were evaluated by western blot.

resultsThe VIP plasmid could effectively improve the pathological state of the OA rats knee joint, significantly decrease the levels of serum TNF-α and IL-2, and clearly increase the levels of VIP and serum IL-4. At the same time, after the OA synoviocytes were treated with the VIP plasmid, the proliferation ability of OA synoviocytes was reduced, the protein expressions of Collagen II and OPG were remarkably up-regulated, and the protein expressions of TNF-α, IL-2, MMP-13 and ADAMTS-5 were significantly down-regulated. In addition, the p-p65 expression decreased and p-IκBα expression increased.

conclusionOsteoarthritis was effectively treated by VIP via inhibiting the NF-κB signaling pathway.

Indexed as

Signal TransductionAnimalsMaleNF-kappa BOsteoarthritis, KneeRatsRats, Sprague-DawleyRecombinant ProteinsSynoviocytesVasoactive Intestinal PeptideNF-kappa BRecombinant ProteinsVasoactive Intestinal PeptideNF-κB signalingOsteoarthritisSynoviocytesVasoactive intestinal peptide

Identifiers

PMID29540226
PMCPMC5851098
OpenAlexW2797429153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.